X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (367) 367
animals (326) 326
male (321) 321
quinolizines - therapeutic use (318) 318
index medicus (262) 262
quinolizines - pharmacology (255) 255
female (208) 208
alkaloids - pharmacology (207) 207
pharmacology & pharmacy (188) 188
alkaloids - therapeutic use (183) 183
rats (146) 146
mice (133) 133
adult (122) 122
quinolizines - administration & dosage (112) 112
middle aged (107) 107
matrine (93) 93
indoles - therapeutic use (92) 92
antiemetics - therapeutic use (86) 86
apoptosis (84) 84
dose-response relationship, drug (84) 84
oxymatrine (73) 73
quinolizines - adverse effects (73) 73
oncology (66) 66
rats, sprague-dawley (65) 65
quinolizines - chemistry (64) 64
quinolizines (58) 58
aged (57) 57
apoptosis - drug effects (57) 57
expression (55) 55
treatment outcome (55) 55
double-blind method (54) 54
cell proliferation - drug effects (52) 52
adolescent (50) 50
alkaloids - chemistry (49) 49
chemistry, medicinal (47) 47
vomiting - prevention & control (46) 46
indoles - administration & dosage (45) 45
quinolizines - pharmacokinetics (45) 45
vomiting - chemically induced (45) 45
indoles - adverse effects (44) 44
signal transduction - drug effects (44) 44
analysis (43) 43
neurosciences (43) 43
cancer (42) 42
cell line, tumor (42) 42
research (42) 42
biochemistry & molecular biology (41) 41
alkaloids - administration & dosage (40) 40
antiemetics - administration & dosage (40) 40
ondansetron (40) 40
in-vitro (39) 39
health aspects (38) 38
double-blind (37) 37
activation (36) 36
antiemetics - adverse effects (36) 36
chemotherapy (36) 36
disease models, animal (36) 36
administration, oral (35) 35
prevention (35) 35
serotonin antagonists - therapeutic use (35) 35
sophora - chemistry (35) 35
nausea - prevention & control (34) 34
varenicline (34) 34
alkaloids (33) 33
nausea - chemically induced (33) 33
ondansetron - therapeutic use (33) 33
care and treatment (32) 32
fluoroquinolones (32) 32
azocines - pharmacology (31) 31
efficacy (31) 31
phytotherapy (31) 31
nicotine (30) 30
nicotinic agonists - pharmacology (30) 30
rats, wistar (30) 30
antineoplastic agents - adverse effects (29) 29
injections, intravenous (29) 29
dolasetron (28) 28
neoplasms - drug therapy (28) 28
proliferation (28) 28
receptors, nicotinic - metabolism (28) 28
rodents (28) 28
anesthesiology (27) 27
biomedicine (27) 27
proteins (27) 27
smoking cessation - methods (27) 27
inhibition (26) 26
pharmacology (26) 26
azocines - therapeutic use (25) 25
drug therapy (25) 25
mice, inbred c57bl (25) 25
nausea (25) 25
oxidative stress (25) 25
postoperative nausea and vomiting - prevention & control (25) 25
cell line (24) 24
clinical trials as topic (24) 24
cytisine (24) 24
pharmacology/toxicology (24) 24
psychiatry (24) 24
quinolizines - metabolism (24) 24
therapy (24) 24
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (578) 578
Chinese (45) 45
German (15) 15
Japanese (12) 12
Italian (8) 8
Russian (4) 4
Polish (3) 3
Spanish (3) 3
French (1) 1
Hungarian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 05/2016, Volume 2016, Issue 5, p. CD006103
Background Nicotine receptor partial agonists may help people to stop smoking by a combination of maintaining moderate levels of dopamine to counteract... 
Smoking [drug therapy] | Varenicline | Humans | RANDOMIZED CONTROLLED-TRIAL | Quinolizines [therapeutic use] | PSYCHIATRIC ADVERSE EVENTS | TOBACCO-DEPENDENCE TREATMENT | Quinoxalines [therapeutic use] | MEDICINE, GENERAL & INTERNAL | Bupropion [therapeutic use] | Nicotine [adverse effects; antagonists & inhibitors] | REPLACEMENT THERAPY | SUSTAINED-RELEASE BUPROPION | Smoking Cessation [methods] | Counseling [methods] | VARENICLINE TREATMENT | METHADONE-MAINTAINED SMOKERS | Randomized Controlled Trials as Topic | Azepines [therapeutic use] | DOUBLE-BLIND PLACEBO | Alkaloids [therapeutic use] | Nicotinic Agonists [adverse effects; therapeutic use] | Azocines [therapeutic use] | LONG-TERM SAFETY | Benzazepines [therapeutic use] | PLACEBO-CONTROLLED TRIAL | Substance Withdrawal Syndrome [prevention & control] | Heterocyclic Compounds with 4 or More Rings [therapeutic use] | Quinolizines - therapeutic use | Azepines - adverse effects | Azocines - therapeutic use | Azocines - adverse effects | Substance Withdrawal Syndrome - prevention & control | Alkaloids - adverse effects | Benzazepines - adverse effects | Smoking - drug therapy | Heterocyclic Compounds, 4 or More Rings - adverse effects | Nicotinic Agonists - therapeutic use | Nicotine - antagonists & inhibitors | Smoking Cessation - methods | Azepines - therapeutic use | Nicotine - adverse effects | Nicotinic Agonists - adverse effects | Heterocyclic Compounds, 4 or More Rings - therapeutic use | Benzazepines - therapeutic use | Counseling - methods | Alkaloids - therapeutic use | Quinolizines - adverse effects | Varenicline - therapeutic use | Bupropion - therapeutic use
Journal Article
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2012, Volume 4, Issue 4, p. CD006103
Journal Article
Journal Article
Journal Article
The American Journal of Chinese Medicine, ISSN 0192-415X, 2014, Volume 42, Issue 3, pp. 543 - 559
To discover and develop novel natural compounds, active ingredients, single herbs and combination formulas or prescriptions in traditional Chinese medicine... 
Combination Formula | Review | Natural Compound | Antitumor | Herb | Traditional Chinese Medicine | FORBESII BOISS EXTRACT | SOPHORA-FLAVESCENS | PANCREATIC-CANCER | CELL-CYCLE PROGRESSION | GANODERMA-LUCIDUM | ANTITUMOR-ACTIVITY | BREAST-CANCER CELLS | MEDICINE, GENERAL & INTERNAL | IN-VITRO | HEPATOCELLULAR-CARCINOMA | INTEGRATIVE & COMPLEMENTARY MEDICINE | NF-KAPPA-B | Quinolizines - therapeutic use | Antineoplastic Agents, Phytogenic | Podophyllotoxin - pharmacology | Quinolizines - isolation & purification | Humans | Molecular Conformation | Alkaloids - isolation & purification | Podophyllotoxin - therapeutic use | Drugs, Chinese Herbal - pharmacology | Molecular Targeted Therapy | Phenanthrenes - isolation & purification | Flavonoids - therapeutic use | Epoxy Compounds - pharmacology | Neoplasms - genetics | Flavonoids - pharmacology | Drugs, Chinese Herbal - therapeutic use | Epoxy Compounds - isolation & purification | Podophyllotoxin - isolation & purification | Diterpenes - pharmacology | Epoxy Compounds - therapeutic use | Amphibian Venoms - chemistry | Diterpenes - therapeutic use | Phenanthrenes - therapeutic use | Plants, Medicinal - chemistry | Alkaloids - pharmacology | Medicine, Chinese Traditional | Diterpenes - isolation & purification | Quinolizines - pharmacology | Amphibian Venoms - pharmacology | Berberine - isolation & purification | Drug Discovery | Neoplasms - drug therapy | Amphibian Venoms - therapeutic use | Berberine - pharmacology | Phenanthrenes - pharmacology | Animals | Drugs, Chinese Herbal - chemistry | Alkaloids - therapeutic use | Flavonoids - isolation & purification | Berberine - therapeutic use | Neoplasms - pathology | Amphibian Venoms - isolation & purification | Drug Combinations | Podophyllotoxin - analogs & derivatives | Antimitotic agents | Medicine, Chinese | Product development | Research | Antineoplastic agents | Health aspects
Journal Article